| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.78M | - | |
| VP | 79.5K | $715.6K | - | |
| VP | 67.4K | $606.5K | - | |
| VP | 65.1K | $585.7K | - | |
| VP | 56.3K | $506.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | Paulson Richard A.79 | President And CEO | Sell | 2,542 | $5.76 | $14,642.43 | -0.4% | -17.8% | -61.4% | |
| Jun 3, 2022 | Mason Michael88 | EVP, CFO, Treasurer | Sell | 601 | $6.04 | $3,630.12 | -0.2% | -16.6% | -63.8% | |
| May 4, 2022 | Paulson Richard A.79 | President And CEO | Sell | 28,502 | $6.23 | $177,509.30 | -2.2% | -35.4% | -58.4% | |
| Feb 28, 2022 | Frenkel Ran78 | EVP, Chief Dev. Officer | Sell | 1,663 | $10.24 | $17,025.13 | -1.0% | -39.2% | -70.8% | |
| Feb 28, 2022 | Mason Michael88 | EVP, CFO &Treasurer | Sell | 2,398 | $10.24 | $24,549.53 | -1.7% | -39.2% | -70.8% | |
| Feb 28, 2022 | Shacham Sharon79 | Chief Scientific Officer | Sell | 12,452 | $10.24 | $127,477.35 | -0.8% | -39.2% | -70.8% | |
| Feb 28, 2022 | Kauffman Michael78 | Director | Sell | 12,452 | $10.24 | $127,477.35 | -0.8% | -39.2% | -70.8% | |
| Feb 17, 2022 | Shah Jatin54 | EVP, Chief Medical Officer | Sell | 1,306 | $12.12 | $15,833.16 | -1.0% | -55.0% | -70.4% | |
| Feb 17, 2022 | Frenkel Ran78 | EVP, Chief Dev. Officer | Sell | 2,929 | $12.12 | $35,509.44 | -2.8% | -55.0% | -70.4% | |
| Feb 17, 2022 | Shacham Sharon79 | Chief Scientific Officer | Sell | 18,167 | $12.12 | $220,245.81 | -1.1% | -55.0% | -70.4% |